CSPC Pharmaceutical Group (1093N) Ownership - Who Owns CSPC Pharmaceutical Group?
CSPC Pharmaceutical Group (1093N) Ownership Overview
- 4.01% Mutual Funds
- 7.57% ETFs
- 88.42% Public Companies and Individual Investors
The ownership structure of CSPC Pharmaceutical Group (MX:1093N) stock is a mix of institutional, retail, and individual investors. Approximately 11.58% of the company’s stock is owned by Institutional Investors, and 88.42% is owned by Public Companies and Individual Investors.
The ownership structure of CSPC Pharmaceutical Group (MX:1093N) stock is a mix of institutional, retail, and individual investors. Approximately 11.58% of the company’s stock is owned by Institutional Investors, and 88.42% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 292,858,677 | Institution | 2.54% | 252,151,321 |
| Ishares | 277,667,629 | Institution | 2.41% | 239,071,829 |
| Vanguard International Equity Index Funds | 135,833,398 | Institution | 1.18% | 116,952,556 |
| Vanguard Star Funds | 116,274,056 | Institution | 1.01% | 100,111,962 |
| Dfa Investment Dimensions Group Inc | 101,358,800 | Institution | 0.88% | 87,269,927 |
| Avantis | 69,115,760 | Institution | 0.60% | 59,508,669 |
| Fidelity Salem Street Trust | 38,761,844 | Institution | 0.34% | 33,373,948 |
| Xtrackers | 35,432,419 | Institution | 0.31% | 30,507,313 |
| Ubs | 29,470,310 | Institution | 0.26% | 25,373,937 |
| Amundi | 28,499,789 | Institution | 0.25% | 24,538,318 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard International Equity Index Funds | 135,833,398 | Institution | 1.18% | 116,952,556 |
| Vanguard Star Funds | 116,274,056 | Institution | 1.01% | 100,111,962 |
| Dfa Investment Dimensions Group Inc | 101,358,800 | Institution | 0.88% | 87,269,927 |
| Fidelity Salem Street Trust | 38,761,844 | Institution | 0.34% | 33,373,948 |
| Tiaa-cref Funds | 13,946,978 | Institution | 0.12% | 12,008,348 |
| Gmo Trust | 9,202,000 | Institution | 0.08% | 7,922,922 |
| Pimco Equity Series | 7,746,000 | Institution | 0.07% | 6,669,306 |
| Vanguard Whitehall Funds | 7,698,855 | Institution | 0.07% | 6,628,714 |
| Northern Funds | 3,812,720 | Institution | 0.03% | 3,282,752 |
| Schwab Capital Trust | 3,414,000 | Institution | 0.03% | 2,939,454 |
FAQ
What percentage of CSPC Pharmaceutical Group (MX:1093N) stock is held by institutional investors?
According to the latest TipRanks data, approximately 11.58% of CSPC Pharmaceutical Group (MX:1093N) stock is held by institutional investors: 4.01% by mutual funds and 7.57% by ETFs.
What percentage of CSPC Pharmaceutical Group (MX:1093N) stock is held by retail investors?
According to the latest TipRanks data, approximately 88.42% of CSPC Pharmaceutical Group (MX:1093N) stock is held by public companies and individual investors.
Who owns the most shares of CSPC Pharmaceutical Group (MX:1093N)?
Vanguard owns the most shares of CSPC Pharmaceutical Group (MX:1093N).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
